SCHEMBL23360460

SCHEMBL23360460

CC(C)(C)OC(=O)N1CCC(Nc2ccnc3c(F)cccc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.51
ALDH1A1 P00352 2/20 0.48
NPC1 O15118 1/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PIM1 P11309 1/20 0.46
PIM2 Q9P1W9 1/20 0.46
JAK1 P23458 1/20 0.45
CCNA2 P20248 1/20 0.45
CDK2 P24941 1/20 0.45
CDK5 Q00535 1/20 0.45
CDK5R1 Q15078 1/20 0.45
CNR1 P21554 2/20 0.45
PARP1 P09874 1/20 0.44
USP30 Q70CQ3 1/20 0.44
IDH1 O75874 1/20 0.44
IDH2 P48735 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29863307 1.00 GPR119 (0.51) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL28834065 0.94 USP30 (0.49) GPR119PIM1PIM2CNR1PARP1
SCHEMBL28834064 0.94 USP30 (0.49) GPR119PIM1PIM2CNR1PARP1
SCHEMBL29933464 0.94 USP30 (0.49) GPR119PIM1PIM2CNR1PARP1
SCHEMBL23359875 0.92 GPR119 (0.51) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL23360477 0.89 ALDH1A1 (0.47) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL29862739 0.89 ALDH1A1 (0.47) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL23360170 0.89 ALDH1A1 (0.49) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL29862457 0.89 ALDH1A1 (0.49) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL23360517 0.88 ALDH1A1 (0.50) GPR119ALDH1A1NPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL GPR119 1940/4885ALDH1A1 439/4885NPC1 2057/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL GPR119 1940/4885ALDH1A1 439/4885NPC1 2057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.